speb/financial-data huggingface dataset:
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 28300000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 28300000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: -30000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: -30000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 12446000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 12446000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 201022000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 36191000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Normalized Income: 71082000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 24162000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: -81588000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Operating Income: 67922000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Operating Income: -20872000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Operating Revenue: 1625472000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 296129000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 12714600.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 12714600.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 30000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 30000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 957000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 957000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 2000663000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 2000663000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 7423000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 7423000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 55490000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 55490000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 26488000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 414220000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 414220000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 6000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 6000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 62439000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 52273000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 321980000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 90585000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Other Payable: 7174000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 7174000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Other Properties: 196102000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 196102000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 25119000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 25119000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Other Special Charges: -24000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Payables: 435029000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Payables: 435029000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 11990000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 11990000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 45576000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 45576000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Pretax Income: 98800000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 24903000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: 0.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -21885000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 100692000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 100692000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 846180000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 137646000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 69101000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 4789000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 4435000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 4435000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -430000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 4319000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 4319000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 963077000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 963077000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 63401000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 132648000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Share Issued: 12714600.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 12714600.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Short Term Debt Payments: -430000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 2118551000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 2118551000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 2111128000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 2111128000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Tax Provision: 33243000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 6266000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.34
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.25
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 222484000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 222484000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -13500000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Total Assets: 2971505000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 2971505000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 2155894000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 2155894000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Total Debt: 337742000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 337742000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 2130530000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 2130530000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Total Expenses: 1557550000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 317001000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 840975000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 840975000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 1326011000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1326011000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 59357000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 59357000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 5644000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 0.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 0.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Tradeand Other Payables Non Current: 22044000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 22044000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Work In Process: 154114000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 154114000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Working Capital: 863875000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 863875000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Write Off: 224000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 175179000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 430448000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 13562815.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 1.18
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 227128000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 18013000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 18013000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 13562815.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.18
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 21530000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — EBIT: 32843000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — EBITDA: 50856000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 203320000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 11534000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 11534000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 5525000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Net Income: 21530000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 21530000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 16005000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 21530000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 21530000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 16005000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -11534000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -11534000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 50856000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 21530000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Operating Income: 28141000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 430448000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 4703000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 76263000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 21309000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 227128000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 18013000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 5305000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
MEDICAMEQ.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 402307000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 207177000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 471698000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 431832000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 775706000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 17094872.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 1.56
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 135628000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 436793000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 436793000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 135628000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 2754105000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 231531000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 2234138000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 350312000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 350312000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 855863000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 8134000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 18567000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 18567000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 17094872.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.56
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 26668000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — EBIT: 36718000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — EBITDA: 55285000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 6587000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 849765000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 240167000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 9889000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 9889000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 687683000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 3140591000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 80614000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 36174000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 36174000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 24940000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Minority Interests: 5525000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Net Income: 26668000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 26668000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 21143000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 26668000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 26668000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 21143000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -9889000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -9889000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 849765000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 2747518000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 29617000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 12000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 55285000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 26668000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Operating Income: 32990000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 471698000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 13562815.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 307281000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 16671000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 2618477000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 430850000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 1000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 3728000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 100302000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 849765000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 26675000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Payables: 480746000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 26829000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 231531000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 18567000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 13562815.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 2754105000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 2747518000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 5686000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 3671095000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 2790279000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 386486000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 2754105000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 438708000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 916990000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1436957000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 61127000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 48914000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 1378275000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 206510000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 469085000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 13509917.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 1.21
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 237096000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 18274000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 18274000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 13509917.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.21
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 16347000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — EBIT: 30829000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — EBITDA: 49103000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 231989000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 9720000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 9720000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Net Income: 16347000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 16347000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 16347000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 16347000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 16347000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 16347000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -9720000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -9720000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 49103000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 16347000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Operating Income: 25479000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 469085000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 5349000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 104507000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 21109000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 237096000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 18274000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 4762000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.23
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 443606000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — +Operating Expense: 836291000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 247426000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — +Total Revenue: 1977697000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 606466000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 400064000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 400064000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 818281000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 818281000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 13562815.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 11759451.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Basic EPS: 7.22
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 3.28
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 37594000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -47778000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 135628000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 135628000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 312642000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 312642000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 312642000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 312642000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -13563000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -79421000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -238287000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 10025000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Change In Payable: -26453000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -156650000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -521335000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 275048000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Common Stock: 135628000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 135628000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 2755500000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 2755500000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 535679000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 0.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 0.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 1017719000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 321964000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Current Assets: 2237341000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 2237341000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Current Debt: 416310000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 416310000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 416310000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 416310000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 879196000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 879196000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 12261000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 12261000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Deferred Tax: 21880000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Depreciation: 72185000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 72185000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 72185000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 17332000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 72185000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 17332000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 13562815.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 11759451.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Diluted EPS: 7.22
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 3.28
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 96413000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 38571000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — EBIT: 154818000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — EBIT: 54427000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — EBITDA: 227003000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — EBITDA: 71759000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — End Cash Position: 312642000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 637158000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -379501000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 0.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 5716000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 5716000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 840921000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 840921000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Gross Profit: 959978000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 284502000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Interest Expense: 34974000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 3830000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 34974000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 3830000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -34974000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 17391000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Inventory: 700795000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 700795000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 3233336000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 3233336000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -30387000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 0.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 0.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 535679000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 145306000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 61526000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 61526000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 61526000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 61526000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 24183000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 23662000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 23662000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Minority Interests: -1551000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Minority Interests: -5899000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 535679000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Net Debt: 165194000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 165194000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Net Income: 96413000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Net Income: 38571000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 96413000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 38571000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 97964000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 44470000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 96413000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 38571000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 96413000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 38571000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 97964000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 97964000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 44470000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Net Interest Income: -34974000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -3830000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 0.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 145306000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 24183000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -34974000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -3830000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: 4710000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Net PPE: 840921000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 840921000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -47778000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 121123000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 2749784000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 2749784000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 31680000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 31680000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 0.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 0.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 227003000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 71759000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Normalized Income: 96413000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 38571000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: -331723000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Operating Income: 123687000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Operating Income: 37076000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Operating Revenue: 1977697000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 606466000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 13562815.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 13562815.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 378992000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 378992000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 24706000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 24706000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 2619872000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 2619872000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 5716000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 5716000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 17583000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 554650000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 554650000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 31132000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 17352000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 417175000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 136103000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Other Properties: 840921000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 840921000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 26631000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 26631000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Payables: 425919000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Payables: 425919000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Pretax Income: 119844000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 50597000.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: 0.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -47778000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 1017719000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 321964000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 72185000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 17332000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Share Issued: 13562815.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 13562815.00
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Short Term Debt Issuance: 121123000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 2755500000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 2755500000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 2749784000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 2749784000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Tax Provision: 21880000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 6127000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.18
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.12
MEDICAMEQ.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -20000000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Total Assets: 3719884000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 3719884000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 2817026000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 2817026000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Total Debt: 477836000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 477836000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 2755500000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 2755500000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Total Expenses: 1854010000.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 569390000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 964384000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 964384000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 1482543000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1482543000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 85188000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 85188000.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 25855000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 25855000.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
MEDICAMEQ.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
MEDICAMEQ.NS balance_sheet (annual, 2026-03-31) — Working Capital: 1358145000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 1358145000.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -143600000.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 33316000.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -9120000.00
MEDICO.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 82984000.00
MEDICO.NS income_statement (annual, 2022-03-31) — Basic EPS: 0.58
MEDICO.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 153687000.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 11800000.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 11650000.00
MEDICO.NS cash_flow (annual, 2022-03-31) — Common Stock Issuance: 124500000.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Current Provisions: 4000000.00
MEDICO.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 82984000.00
MEDICO.NS income_statement (annual, 2022-03-31) — Diluted EPS: 0.58
MEDICO.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 41297000.00
MEDICO.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 28348000.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Goodwill: 0.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 313063000.00
MEDICO.NS income_statement (annual, 2022-03-31) — Interest Income: 703000.00
MEDICO.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 703000.00
MEDICO.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: -2332000.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Investment Properties: 0.00
MEDICO.NS cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 124500000.00
MEDICO.NS cash_flow (annual, 2022-03-31) — Issuance Of Debt: 0.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 23079000.00
MEDICO.NS cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 0.00
MEDICO.NS cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -53879000.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Long Term Provisions: 484000.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 145593000.00
MEDICO.NS cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 124500000.00
MEDICO.NS income_statement (annual, 2022-03-31) — Net Income Discontinuous Operations: 0.00
MEDICO.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: -53879000.00
MEDICO.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: -53879000.00
MEDICO.NS cash_flow (annual, 2022-03-31) — Net Other Financing Charges: 1000.00
MEDICO.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: 1000.00
MEDICO.NS cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: -3900000.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 0.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 0.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 484000.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 8329000.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 45424000.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Other Payable: 3714000.00
MEDICO.NS income_statement (annual, 2022-03-31) — Other Special Charges: 391000.00
MEDICO.NS cash_flow (annual, 2022-03-31) — Pension And Employee Benefit Expense: 0.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 431000.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 1622000.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 57018000.00
MEDICO.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 315000.00
MEDICO.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 315000.00
MEDICO.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: -53879000.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 0.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 166746000.00
MEDICO.NS cash_flow (annual, 2022-03-31) — Sale Of Investment: 0.00
MEDICO.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 90283000.00
MEDICO.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 118631000.00
MEDICO.NS cash_flow (annual, 2022-03-31) — Short Term Debt Payments: -3900000.00
MEDICO.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 62995000.00